A rapid LC-MS/MS assay for detection and monitoring of underivatized branched-chain amino acids in maple syrup urine disease

[1]  M. Uittenbogaard,et al.  Clinical Insights into Mitochondrial Neurodevelopmental and Neurodegenerative Disorders: Their Biosignatures from Mass Spectrometry-Based Metabolomics , 2021, Metabolites.

[2]  Yan Ming Tan,et al.  Plasma Metabolome and Lipidome Associations with Type 2 Diabetes and Diabetic Nephropathy , 2021, Metabolites.

[3]  R. Henrique,et al.  Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics , 2021, Metabolites.

[4]  D. Wishart,et al.  A Multi-Platform Metabolomics Approach Identifies Urinary Metabolite Signatures That Differentiate Ketotic From Healthy Dairy Cows , 2021, Frontiers in Veterinary Science.

[5]  C. Salvador,et al.  Method comparison of HPLC-ninhydrin-photometry and UHPLC-PITC-tandem mass spectrometry for serum amino acid analyses in patients with complex congenital heart disease and controls , 2020, Metabolomics.

[6]  Liang Li,et al.  Chemical derivatization in LC-MS-based metabolomics study , 2020 .

[7]  D. Wishart,et al.  A Comprehensive Targeted Metabolomic Assay for Urine Analysis. , 2020, Analytical chemistry.

[8]  M. Sargsyan,et al.  Development and validation of LC-MS/MS method for determination of branched chain amino acids and α-keto acids in human plasma , 2020 .

[9]  N. Zhang,et al.  Serum branched-chain amino acids are associated with leukocyte telomere length and frailty based on residents from Guangxi longevity county , 2020, Scientific Reports.

[10]  C. Salvador,et al.  Targeted metabolomic analysis of serum amino acids in the adult Fontan patient with a dominant left ventricle , 2020, Scientific Reports.

[11]  D. Wishart,et al.  The Urinary Metabolome of Healthy Newborns , 2020, Metabolites.

[12]  E. Puffenberger,et al.  Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes. , 2020, Molecular genetics and metabolism.

[13]  Darryl B. Hardie,et al.  Concentration Determination of >200 Proteins in Dried Blood Spots for Biomarker Discovery and Validation* , 2020, Molecular & Cellular Proteomics.

[14]  R. Boriack,et al.  Quantitative amino acid analysis by liquid chromatography‐tandem mass spectrometry using low cost derivatization and an automated liquid handler , 2019, JIMD reports.

[15]  G. Juhász,et al.  Development, validation and application of LC-MS/MS method for quantification of amino acids, kynurenine and serotonin in human plasma. , 2019, Journal of pharmaceutical and biomedical analysis.

[16]  L. Allen,et al.  Validation and Application of Biocrates AbsoluteIDQ® p180 Targeted Metabolomics Kit Using Human Milk , 2019, Nutrients.

[17]  Daniel Raftery,et al.  NMR Spectroscopy for Metabolomics Research , 2019, Metabolites.

[18]  O. Fiehn,et al.  Rapid LC-MS/MS quantification of cancer related acetylated polyamines in human biofluids. , 2019, Talanta.

[19]  P. Widłak,et al.  MS-Based Proteomic Analysis of Serum and Plasma: Problem of High Abundant Components and Lights and Shadows of Albumin Removal. , 2019, Advances in experimental medicine and biology.

[20]  M. Boyce,et al.  Development and validation of a simple LC-MS/MS method for the simultaneous quantitative determination of trimethylamine-N-oxide and branched chain amino acids in human serum , 2018, Analytical and Bioanalytical Chemistry.

[21]  C. Borchers,et al.  Isotope-labeling derivatization with 3-nitrophenylhydrazine for LC/multiple-reaction monitoring-mass-spectrometry-based quantitation of carnitines in dried blood spots. , 2018, Analytica chimica acta.

[22]  R. Russell,et al.  Untargeted Metabolomics of Extracts from Faecal Samples Demonstrates Distinct Differences between Paediatric Crohn’s Disease Patients and Healthy Controls but No Significant Changes Resulting from Exclusive Enteral Nutrition Treatment , 2018, Metabolites.

[23]  D. Ennulat,et al.  Current Practices and Challenges in Method Validation , 2018, Toxicologic pathology.

[24]  David S. Wishart,et al.  HMDB 4.0: the human metabolome database for 2018 , 2017, Nucleic Acids Res..

[25]  S. Rehman,et al.  Development of a mixed‐mode chromatography with tandem mass spectrometry method for the quantitative analysis of 23 underivatized amino acids in human serum , 2017, Journal of pharmaceutical and biomedical analysis.

[26]  P. Blackburn,et al.  Maple syrup urine disease: mechanisms and management , 2017, The application of clinical genetics.

[27]  K. Adeli,et al.  The Canadian laboratory initiative on pediatric reference intervals: A CALIPER white paper , 2017, Critical reviews in clinical laboratory sciences.

[28]  Ruiting Li,et al.  A novel liquid chromatography tandem mass spectrometry method for simultaneous determination of branched-chain amino acids and branched-chain α-keto acids in human plasma , 2016, Amino Acids.

[29]  P. Fan,et al.  A novel method for detecting amino acids derivatized with phenyl isothiocyanate by high-performance liquid chromatography-electrospray ionization mass spectrometry , 2015 .

[30]  L. Sun,et al.  Association of branched-chain amino acids with coronary artery disease: A matched-pair case-control study. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[31]  V. Peters,et al.  Physician’s guide to the diagnosis, treatment, and follow-up of inherited metabolic diseases , 2014, Journal of Inherited Metabolic Disease.

[32]  Susan E. Abbatiello,et al.  Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach* , 2014, Molecular & Cellular Proteomics.

[33]  J. Vockley,et al.  Disorders of Leucine, Isoleucine, and Valine Metabolism , 2014 .

[34]  Ruiyue Yang,et al.  Rapid and Precise Measurement of Serum Branched-Chain and Aromatic Amino Acids by Isotope Dilution Liquid Chromatography Tandem Mass Spectrometry , 2013, PloS one.

[35]  Xuefan Gu,et al.  Application of liquid chromatography-tandem mass spectrometry in the diagnosis and follow-up of maple syrup urine disease in a Chinese population , 2013, Journal of pediatric endocrinology & metabolism : JPEM.

[36]  Steven J. Novick,et al.  Directly testing the linearity assumption for assay validation , 2013 .

[37]  T. Wood,et al.  Quantification of branched-chain amino acids in blood spots and plasma by liquid chromatography tandem mass spectrometry for the diagnosis of maple syrup urine disease. , 2011, Journal of separation science.

[38]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[39]  D. Chuang,et al.  Maple syrup urine disease in Cypriot families: identification of three novel mutations and biochemical characterization of the p.Thr211Met mutation in the E1alpha subunit. , 2009, Genetic testing and molecular biomarkers.

[40]  K. Strauss,et al.  Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD). , 2008, Clinical chemistry.

[41]  M. Bennett,et al.  A rapid ultra performance liquid chromatography tandem mass spectrometric method for measuring amino acids associated with maple syrup urine disease, tyrosinaemia and phenylketonuria , 2007, Annals of clinical biochemistry.

[42]  B. Matuszewski,et al.  Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. , 2003, Analytical chemistry.

[43]  Timothy Block,et al.  Efficient and Specific Removal of Albumin from Human Serum Samples* , 2003, Molecular & Cellular Proteomics.

[44]  R. Sherwood.  Amino acid measurement in body fluids using PITC derivatives. , 2000, Methods in molecular biology.

[45]  U. Wendel,et al.  Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. , 1999, Clinical chemistry.

[46]  A. Mccarthy.  Development , 1996, Current Opinion in Neurobiology.

[47]  S. Moore,et al.  Automatic recording apparatus for use in the chromatography of amino acids. , 1958, Federation proceedings.